HomeAbout UsContact Us1-800-477-6037
Medical Device Daily
Archive Search

User ID


Forgot password

Remember my login

New User ?

Products & Services
Medical Device Daily
Medtech Resources
BioWorld Executive Compensation Report 2014
MDD State of the Industry Report 2013
BioWorld and Medical Device VC Directory 2012
MDD Innovations Report 2011
MDD Interviews Report
Biotech SuperBook
Arthritis Report 2009
MDD Perspectives
BioWorld Today
Biotech Resources
Perspectives Blog
PMA and 501(k) Approvals

Today's Issue of Medical Device Daily

Friday, August 1, 2014

Today's Headlines

FDA advisory committee: EDAP's Ablatherm PMA falters at adcomm over poor efficacy data

GAITHERSBURG, Maryland — The Ablatherm PMA by EDAP (Lyon, France) faltered at a July 30 FDA advisory committee despite that the device has been available in Europe for more than a decade, raising questions once again about FDA's higher regulatory standards and the agency's willingness to accept outside-U.S. data for device applications. Enrollment issues associated with the pivotal trial for the Ablatherm device, which boasts more than 20,000 uses in OUS settings, forced the sponsor to make use of a post-hoc analysis assembled prior to completion of the trial, but the panelists largely brushed aside what some said was a reasonable safety record in an 8-0 vote that the benefits do not outweigh the risks.

Unapproved changes: Recent FDA warning letters

FDA's warning letters to device makers serve as vehicles for all kinds of statements, including statements about when a device maker needs a new regulatory filing. Lately it seems that has come up a lot more, but is that a trend or just a blip on the screen? (MDD Perspectives)

ReWalk Robotics secures FDA clearance for exoskeleton for paraplegic patients

In 1997, Amit Goffer, an Israeli inventor, was severely paralyzed as a result of an ATV accident. Not content with his condition or the level of innovation available for paralyzed patients, Goffer, who is now a quadriplegic, began work on mobility devices. His work paid off as he eventually developed an exoskeleton to help paraplegic patients walk.

MDD Home   |   About MDD   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement   |   Free Alerts

Part of Thomson Reuters
thomsonreuters.com | lifesciences.thomsonreuters.com | BioWorld.com | medicaldevicedaily.com